Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14365/6192
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBaris, Elif-
dc.contributor.authorPortakal, Huseyin Saygin-
dc.date.accessioned2025-05-25T19:24:27Z-
dc.date.available2025-05-25T19:24:27Z-
dc.date.issued2025-
dc.identifier.issn2587-2087-
dc.identifier.urihttps://doi.org/10.26650/IstanbulJPharm.2025.1441299-
dc.identifier.urihttps://hdl.handle.net/20.500.14365/6192-
dc.description.abstractBackground: Lavandula stoechas, commonly known as lavender, has traditionally been used in various therapeutic applications, including smoking cessation. The molecular interaction of Lavandula stoechas compounds with the alpha 4 beta 2 nicotinic acetylcholine receptors, which are crucial for smoking cessation, is not well understood. This study aims to analyze these interactions and compare them with the known smoking cessation drug varenicline tartrate. Methods: Molecular docking analysis was performed on essential compounds of Lavandula stoechas to assess their binding affinities to the alpha 4 beta 2 nicotinic acetylcholine receptors. The study utilized the crystal structure of the receptor and conducted virtual drug screening using AutoDock Vina in the PyRx Virtual ScreeningTool. ADME (Absorption, Distribution, Metabolism, and Excretion) and toxicity profiles were also predicted using in silico methods. Results: The molecular docking revealed that several Lavandula stoechas compounds exhibited significant binding affinities to the alpha 4 beta 2 receptor. Compounds with the highest binding affinities were identified and compared with varenicline. The ADME and toxicity profiles indicated that these compounds had more favorable properties than varenicline, suggesting their potential as alternative smoking cessation agents. Discussion: The findings demonstrate that Lavandula stoechas contains compounds with significant binding affinities to the alpha 4 beta 2 nicotinic acetylcholine receptors, similar to varenicline. This indicates a potential role for Lavandula stoechas in smoking cessation therapy. The favorable ADME and toxicity profiles of these compounds further support their potential as alternatives to current smoking cessation drugs. This study paves the way for further research into the therapeutic applications of Lavandula stoechas in smoking cessation.en_US
dc.language.isoenen_US
dc.publisherIstanbul Univ, Fac Pharmacyen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMolecular Dockingen_US
dc.subjectAlpha 4 Beta 2 Nicotinic Receptoren_US
dc.subjectVareniclineen_US
dc.subjectLavandula Stoechasen_US
dc.subjectSmoking Cessationen_US
dc.titleExploring the Potential of Lavandula Stoechas in Smoking Cessation: a Molecular Docking Study of Α4β2 Nicotinic Acetylcholine Receptor Interactionsen_US
dc.typeArticleen_US
dc.identifier.doi10.26650/IstanbulJPharm.2025.1441299-
dc.departmentİzmir Ekonomi Üniversitesien_US
dc.identifier.volume55en_US
dc.identifier.issue1en_US
dc.identifier.startpage134en_US
dc.identifier.endpage148en_US
dc.identifier.wosWOS:001485691900016-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.scopusqualityN/A-
dc.identifier.wosqualityN/A-
dc.description.woscitationindexEmerging Sources Citation Index-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
item.openairetypeArticle-
crisitem.author.dept09.01. Basic Medical Sciences-
crisitem.author.dept05.08. Genetics and Bioengineering-
Appears in Collections:WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Show simple item record



CORE Recommender

Page view(s)

18
checked on Jul 7, 2025

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.